Scientech Research »

Parabilis Medicines shares owned by Scientech Research

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-06-30 $262k 9.6k 27.37

More positions owned by Scientech Research

MaxLinear (MXL)
Fuelcell Energy Com New (FCEL)
Astera Labs (ALAB)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Applied Materials (AMAT)
Palo Alto Networks (PANW)
Tesla Motors (TSLA)
Crowdstrike Hldgs Cl A (CRWD)
Tempus Ai Cl A (TEM)
Sandisk Corp (SNDK)
Strategy Cl A New (MSTR)
Moderna (MRNA)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Nebius Group Shs Class A (NBIS)
Quantinuum Cl A Com

View all positions for Scientech Research

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines